Mohren M, Daikeler T, Engel A, Guenaydin I, Koetter I
Klinik für Hämatologie/Onkologie, Universität Magdeburg, Leipziger Str. 44, 39120, Magdeburg, Germany.
Z Rheumatol. 2004 Dec;63(6):490-4. doi: 10.1007/s00393-004-0593-4.
The antiphospholipid syndrome is characterized by thromboembolic events and/or recurrent miscarriages in the presence of anticardiolipin antibodies and/or a lupus anticoagulant. Anticardiolipin antibodies are detected by ELISA whereas lupus anticoagulant detection includes a variety of coagulometric tests. However, a large number of patients with suspected antiphospholipid syndrome are anticoagulated with either heparin or coumadin when evaluated for the presence of a lupus anticoagulant and false positive test results may ensue, thus making coagulometric testing unreliable in this situation. Modifications of standard coagulometric tests have been suggested in order to circumvent this problem and studies of several patient cohorts have shown that the majority of patients with the antiphospholipid syndrome are anticardiolipin positive. However diagnosis in patients receiving anticoagulation remains a difficult task.
抗磷脂综合征的特征是在存在抗心磷脂抗体和/或狼疮抗凝物的情况下出现血栓栓塞事件和/或反复流产。抗心磷脂抗体通过酶联免疫吸附测定(ELISA)检测,而狼疮抗凝物检测包括多种凝血检测。然而,大量疑似抗磷脂综合征的患者在接受狼疮抗凝物评估时使用肝素或香豆素进行抗凝,可能会出现假阳性检测结果,因此在这种情况下凝血检测不可靠。为了规避这个问题,有人建议对标准凝血检测进行修改,对几个患者队列的研究表明,大多数抗磷脂综合征患者抗心磷脂抗体呈阳性。然而,对于正在接受抗凝治疗的患者进行诊断仍然是一项艰巨的任务。